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Abstract
Background
Benign biliary stricture is a rare condition and the majority of the cases are caused by opera-
tive trauma or chronic inflammation based on various etiology. Although the initial results of
endoscopic, percutaneous and surgical treatment are impressive, no comparison about
long term stricture resolution is available.
Aims
The goal of this study was to compare the long term disease free survival in benign biliary
strictures with various etiology after surgery, percutaneous transhepatic—and endoscopic
treatment.
Methods
PubMed, Embase, and Cochrane Library were searched by computer and manually for pub-
lished studies. The investigators selected the publications according to the inclusion and
exclusion criteria, processed the data and assessed the quality of the selected studies.
Meta-analysis of data of 24 publications was performed to compare long term disease free
survival of different treatment groups.
Results
Compared the subgroups surgery resulted in the highest long term stricture resolution rate,
followed by the percutaneous transhepatic treatment, the multiple plastic stent insertion and
covered self-expanding metal stents (SEMS), however the difference was not significant. All
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compared methods are significantly superior to the single plastic stent placement. Long
term stricture resolution rate irrespectively of any therapy is still not more than 84%.
Conclusions
In summary, the use of single plastic stent is not recommended. Further randomized studies
and innovative technical development are required for improving the treatment of benign bili-
ary strictures.
Introduction
Benign biliary stricture is a rare condition and majority of the cases are caused by operative
trauma, mainly after open, or laparoscopic cholecystectomy [1] [2]. The second most common
cause is the fibrosis at the site of a surgical anastomosis [1]. Other conditions could also lead to
benign bile duct obstruction like chronic pancreatitis, sclerosing cholangitis, cholelithiasis,
impacted stones, sphincterotomy and infection of the biliary tract [3].
The symptoms vary in wide range from asymptomatic presence to complete obstruction
with jaundice, pain, pruritus, biliary stones, cholangitis and biliary cirrhosis[3].
At the moment there are no ideal treatment for this disease, therefore come to a decision
between the therapies is individual. The reocclusion rate is unacceptably high in all proce-
dures, which is around 20% [2]. Real long term follow-up still does not exist making the com-
parison almost impossible.
The bottom line of surgical approach is to restore the bilio-digestive continuity. This could
be reached by hepaticojejunostomy, choledochojejunostomy, or intrahepatic cholangiojeju-
nostomy. The most preferable solution is hepaticojejunostomy in benign biliary strictures,
however most of these patients are poor candidates for surgery due to malnutrition, cirrhosis,
and portal hypertension [2, 4, 5].
The minimal invasive therapies mean repeatable interventions, which raise the amount of
complications, such as cholangitis, bleeding or perforation. The type of the endoprothesis and
the etiology of the stricture can also determine the result of the intervention. The most periph-
eral treatment of benign biliary stricture is balloon dilatation by endoscopic or percutaneous
manner. Percutaneous access could worsen life quality thank to the drainage for a shorter
period. Single plastic stents used for bridging biliary obstruction are easy to apply and inexpen-
sive, but have insufficient diameter and therefore short stent patency, which is requiring
replacement every 2–3 months. Therefore, a widely used and most preferable alternative is a
multiple plastic stent insertion. It is very effective, but the stent patency is short and additional
endoscopic procedures required. Covered self-expandable metal stent can achieve larger diam-
eter, providing longer stent patency with less endoscopic interventions, but is reported to have
80% to 90% long-term success rate after stent removal, which is still unacceptably high in a
benign disease with long life expectance [6]. Therewithal, self-expandable metal stent has sev-
eral early and late complications, such as biliary infection, pancreatitis, bleeding, perforation,
and particularly early stent migration[3] [5, 7].
Considering the benefits and disadvantages, the best choice currently for benign stricture
is the usage of multiple plastic stents, however covered self-expendable metal stents show a
promising future as well [8].
Running through the literature there are numerous studies about success rate and short
term disease free survival of different therapeutic modalities, but no randomized multicentric
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studies exists where the long term results of different treatments could be compared. The aim
of writing a meta-analysis on benign biliary disease, that this field in medicine is still unsolved
and the question whether surgery, endoscopy, or transhepatic biliary intervention is the gold
standard is still open.
Materials and Methods
Materials
All published journal articles, which were related to benign biliary stricture were searched in
three main electronic databases, last search happened in 28.02.2016. It was not augmented
with hand search. Computer research was done in databases of PubMed, Embase and
Cochrane Library by three independent authors. The keywords were the following: benign
biliary stricture, bile duct stricture, benign biliary obstruction, chronic pancreatitis, post-
cholecystectomy, biliary stricture, biliary anastomosis, stent, surgery. (Database were nar-
rowed by: benign biliary stricture AND stent AND surgery, chronic pancreatitis AND stent
AND surgery, benign biliary obstruction AND surgery, benign biliary stricture AND stent,
benign biliary stricture AND surgery, chronic pancreatitis AND stent, chronic pancreatitis
AND surgery, post-cholecystectomy AND stent, post-cholecystectomy AND surgery, biliary
stricture AND surgery, biliary stricture AND stent, biliary anastomosis AND surgery, biliary
anastomosis AND stent, bile duct stricture AND stent, bile duct stricture AND surgery).
We excluded languages other than English. Based on the accelerated development of vari-
ous endobiliary stents we decided to exclude publications about endoscopy before 2000. At the
other therapeutic modalities there was no publication date restriction. Mesh words and free
words were combined and the selection was performed manually.
Methods
Inclusion criteria. Benign strictures were included only. The disease types were chronic
pancreatitis, postoperative stricture and iatrogenic trauma. All three treatments were included:
surgery, endoscopic and percutaneous intervention. We evaluated all types of stents and their
use: single plastic stent, multiple plastic stent, metal stent and fully covered metal stent. The
surgical methods were choledochoduodenostomy, choledochojejunostomy, hepatoduodenost-
omy and hepaticojejunostomy. Both retrospective and prospective studies were accepted. Only
publications with at least one-year follow-up after the close of the intervention according every
single patient (definitive removal of stent) were included.
Exclusion criteria. All studies were excluded where the follow-up after the close of the
interventional period were shorter than one year. To accurately evaluate the studies just full
texts were accepted. Follow-up time had to be clearly identified or calculated as disease free
survival and follow up time. Poor quality, repeated reports and mistakable results were not
accepted.
Literature Screening, Quality Assessment, and Data Extraction
The literature was screened by the investigators independently, the quality of the studies was
based on our inclusion and exclusion eligibility criteria. The data in all studies were then
extracted before a cross-check of the results. The systematic review was conducted following
the Preferred Reporting Items for Systematic Reviews and MetaAnalysis (PRISMA) guidelines
[9].
According to the long term success rate numerous publications include data of patients
into the final statistics who lost during the follow-up, other publications ignore that patients.
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Therefore, we reevaluated the long term success rates and patient numbers in order to get
comparable results: we subtracted the number of the patients lost during the follow up from
the number of patients followed and divided this number (Fig 1).
Statistical Analysis
All meta-analysis were performed with random effect model using the Der Simonian and
Laird method. Q-statistics and I2 indicator were calculated in each case to assess heterogeneity.
If the Q test is significant (p<0.1) it implies that the effect sizes are more different from each
other than it is expected due to random chance. In this case the diversity can be attributed to
different clinical methods or the observed patients participating in the studies. I2 indicator
shows the percentage of effect size variability that cannot be attributed to random chance but
other factors mentioned above.
During the analysis we had to realize that the follow up times reported by the authors varied
in a very wide range, even within the same study. The biggest challenge of this work was to
handle this difficulty and investigate whether the results effect the final conclusion. We used
an alternative weighting method as well along with the conventional random effect weighting
procedure: we multiplied the sample sizes with the (mean or median) follow up years making
it possible for the follow up time to contribute to the weights. Bigger sample size results in
smaller standard error which yields a bigger weight to the specific study and it allows us to see
how the result change if we take into account this information in the weights. Comparing the
results of the conventional weighting (Figs 2 and 3) and the one altered by the follow up time
(Figs 4 and 5), the conclusions are robust concerning this difference. The two weighting meth-
ods yields almost exactly the same estimates and therefore do not affect the conclusion of the
Fig 1. PRISMA diagram for the study.
doi:10.1371/journal.pone.0169618.g001
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analysis. To prove that the success rates show no association with the follow up times, we per-
formed a meta regression. During this investigation we found that the result does not support
the hypothesis that longer follow up time associates with bigger success rate (Coefficient of fol-
low up time = 0.1 p = 0.18). We investigated the same question by the different techniques
(subgroups) because even if there is no association concerning all of the studies there could be
one in the different subgroups. However, the results show no association in either of the sub-
groups. In case of single plastic there were not enough studies to perform the meta regression
(S2 Fig).
To compare the long term success rates of different treatments, we used subgroup analysis,
p< 0.05 indicating significant difference
Finally, we tested the presence of publication bias using Egger’s test using p< 0.1 for detect-
ing significant bias.
Comprehensive Meta-Analysis Software (Biostat Inc.) and Stata 11 SE (Stata Corp.) were
used for the computations and graphs.
Results
Characteristics of the included studies
According to the inclusion and exclusion criteria a total of 24 articles were included in the
present meta-analysis. One of the article contained two groups, which were calculated individ-
ually. 14 publications of them were retrospective cohort studies, 11 were prospective trials, one
of them contained both retrospective and prospective results. No randomized controlled study
was found.
Fig 2. Forest plot comparing long term stricture resolution in different subgroups using modified rate
with ordinary weighting.
doi:10.1371/journal.pone.0169618.g002
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The publications were divided into 3 main subgroups according to the therapeutic modal-
ity: 6 publications in surgery, 13 in endoscopic and 6 in percutaneous transhepatic treatment.
Endoscopic interventions were further classified into 3 subgroups based on the stent material:
3 with single plastic stent, 5 with multiple plastic stent and 5 with covered metal stent insertion.
(Table 1 [10–33])
Publication bias analysis
The Egger’s test showed no indication of publication bias (two sided p = 0,793) in long term
success rates.
Subgroup analysis of modified long term success rate
Six studies reported the long term disease free survival of surgical intervention. As shown in
Fig 2, the weighted mean of the surgical group was (ES 0,84; 95% CI [0,76; 0,93]). Within the
endoscopically treated group, the weighted long term success rate of 3 studies with single plas-
tic stent insertion was (ES 0,23; 95% CI [-0,01; 0,46]), 5 studies with multiple plastic stent
insertion was (ES 0,79; 95% CI [0,69; 0,89]) and 5 studies with covered metal stent was (ES
0,76; 95% CI [0,62; 0,89]). The pooled mean value of percutaneous transhepatic drainage
proved to be (ES 0,81; 95% CI [0,71; 0,90]). These data do not differ significantly from data
with follow-up weighting discussed previously (Fig 4).
Comparing the data of different groups by subgroup analysis shows no significant differ-
ence between surgical intervention, percutaneous transhepatic intervention and endoscopic
multiple plastic stent or covered metal stent insertion (surgery vs. covered metal stent p = 0,19;
Fig 3. Forest plot comparing long term stricture resolution in different subgroups using originally
published rate with ordinary weighting.
doi:10.1371/journal.pone.0169618.g003
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surgery vs. multiple plastic stent p = 0,335; PTD—covered metal stent p = 0,342). However sin-
gle plastic stent insertion indicates significantly worse long term disease free survival com-
pared any other therapeutic modalities (covered metal stent—single plastic stent p = 0,001;
multiple plastic stent—single plastic stent p< 0,001; PTD—single plastic stent p< 0,001; sur-
gery—single plastic stent p< 0,001).
Subgroup analysis of originally published long term success rate
Calculating with the previously presented subgroups we compared the long term success rate
of different groups originally published in the publications but no difference was detected sur-
gery—ES 0,84; 95% CI [0,75; 0,93], single plastic stent insertion—ES 0,23; 95% CI [-0,01; 0,46],
multiple plastic stent insertion—ES 0,79; 95% CI [0,69; 0,89], covered metal stent insertion—
ES 0,75; 95% CI [0,65; 0,85], percutaneous transhepatic intervention—(ES 0,75; 95% CI [0,66;
0,84]). (Fig 3). These data do not differ significantly from data with follow-up weighting dis-
cussed previously (Fig 5).
Discussion
The benign biliary strictures represent a clinical diagnostic category which is extremely wide
under many points of view. The clinically relevant approach is that all bile duct strictures in
patients with obstructive jaundice should be considered malignant unless a benign etiology is
definitively identifiable. However, the diagnostic arsenal has some uncertainty in store. ERCP
or PTC with sampling is indispensable but it is limited by low sensitivity. The addition of
FISH, Kras/p53 mutation analysis can give further important evidence that may help improve
Fig 4. Forest plot comparing long term stricture resolution in different subgroups using modified rate
with follow-up weighting.
doi:10.1371/journal.pone.0169618.g004
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the diagnostic yield. EUS-FNA has been shown to be effective in diagnosing malignancy in
patients with biliary strictures and should be considered as the initial endoscopic modality in
all patients with suspected biliary strictures without obstructive jaundice. Use of intraductal
ultrasound and cholangioscopy is limited due to the availability. Taking into consideration the
above mentioned limitation of the diagnosis, publications selected for this meta-analysis
undisputedly excluded the malignant diseases.
In order to reduce biases and limitations from the benign etiologies we focused on chronic
pancreatitis, postoperative stricture and iatrogenic trauma where every examined modality
can have a role in the treatment.
Several publications and randomized studies exist about short term results of the treatment
of benign bile duct strictures.[34, 35] These articles shows promising clinical success rates of
the endoscopic treatment but the results are still hardly acceptable in a benign disease. As
above mentioned, randomized controlled prospective studies focusing on the long term results
of the treatment of benign biliary stenosis are not published in the literature.
There are different treatment procedures available for bile duct stenosis but the gold stan-
dard method is still not defined. According to the clinical practice endoscopic treatment and
stent implantation with or without balloon dilatation is widely used as first line therapy,
since it is effective, safe, noninvasive and repeatable. Dilation of strictures is mainly used as a
supplementary technique before stent insertion and rarely as a single method. In case of
benign strictures plastic stents are the first choice, and non-covered self-expandable metal
stents are almost exclusively used in malignant diseases. According to the paper of Katanuma
et al. single plastic stent insertion usually does not achieve good short and long term results
Fig 5. Forest plot comparing long term stricture resolution in different subgroups using originally
published rate with follow-up weighting.
doi:10.1371/journal.pone.0169618.g005
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in terms of benign biliary stricture resolution due to their limited stent diameter, single plas-
tic stents have only short-term patency rates [36]. Multiple stenting published by Costa-
magna is a more aggressive treatment associated with better results[37] [38]. Although some
authors are preferring multiple plastic stent insertion due to the longer occlusion free sur-
vival [39], these procedures also have limitations: patient compliance is needed and the risk
of stent related complications such as cholangitis is higher. Multiple plastic stents provide
bigger lumen size than single stents because the lumen of the implanted stents adds up and
the more stent is implanted the less chance is there for an obstruction. There are wide variety
of complications that have been reported from the harmless transient stent clogging to severe
cholangitis and death.
However, the number of publications about partially or fully covered metal stents used in
benign cases are increasing although the indication of these prosthesis are still controversial [3,
14, 40, 41]. Covered self-expandable metal stents appear as a good alternative option, since
they have an increased radial diameter, longer stent patency compared to single plastic stents,
easier insertion technique and similar efficacy. It should be noted that stent migration is the
major problem of fully covered self-expanding metal stents (FCSEMS) [42]. To minimize stent
migration, numerous technical modification was done. However, data that clearly demonstrate
the superiority of FCSEMS over multiple plastic stenting are lacking[43]. There are also several
technical situations where endoscopic procedure cannot be carried out such as a stricture of a
bilio-digestive anastomosis which can make endoscopic intervention cumbersome compared
to surgery[44].
According to the above mentioned there is a lack of published comparisons and random-
ized trials, so the acceptable long term effectivity of endoscopic treatment is still doubtful. Due
to the heterogeneity of the disease we can get result in a wide spectrum. Cholestasis in patients
with chronic pancreatitis may be remedied by endoscopic or surgical means, although endo-
scopic stent therapy is of lasting success for more than 12 months in only one-third of patients
(English language version of the S3-consensus guidelines on chronic pancreatitis: Definition,
etiology, diagnostic examinations, medical, endoscopic and surgical management of chronic
pancreatitis—Englischsprachige Version der S3-Leitlinie Chronische Pankreatitis A. Hoffme-
ister1 et al.). A prospective study by Kahl showed an even poorer long-term effect of stent ther-
apy of benign biliary stricture associated to calcifying chronic pancreatitis [29, 45]. The
german guideline recommends surgical intervention, if symptoms or cholestasis persist after
temporary endoscopic therapy (Level of evidence grade 2b, recommendation grade B, strong
consensus)[45].
The role of percutaneous intervention is disputed as well. While endoscopic treatment of
patients with previous surgery is technically difficult and anatomical location of the stricture
can also result in a low success rate, percutaneous treatment has to be an option in referral cen-
ters with adequate case volume and expertise. The use of extracorporeal drain may affect
patient’s quality of life. PTD should be an option in cases, where surgery is unsuitable due to
severe comorbidities or technical challenge such as portal hypertension. The modality allows
almost all techniques used in endoscopy: balloon dilatation, stent implantation.
New technologies—such as biodegradable stents or intraductal radiofrequency ablation—
are under development to overcome the drawbacks of the existing procedures but there are no
evidence about their long term efficacy on human population.[46–48] [49]
Initiated by the previously mentioned difficulties of treatments and lack of clinical data
with high evidence we compared several treatment possibilities to find out which is the most
effective in long term. Retrospective and prospective studies were also included, both type of
studies can give evidences with acceptable and comparable quality in term of long term success
rate. Related to that topic some other questions would be interesting as minor and major
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complications, quality of life etc, but the published data of the selected publications, the retro-
spective way of data collection does not allow us compare data and frame conclusions in these
terms.
Many studies imply that metal or plastic stenting, PTD or surgery is the optimal procedure
but none of them reached a consensus and the question remained unanswered. It should be
noted that the aim of that study is to compare long term stricture resolution rate of different
modalities. However, it is clear that long term disease free survival alone cannot turns the
scales. Other parameters such as clinical success rate, complications, life quality, finances influ-
encing the argument should be considered as well. We reviewed a numerous studies written in
this topic to find out the answer. As we filtered the articles and compared the results we faced
many obstacles that made our results limited. All articles were nonrandomized, the methods
applied in the studies were not standard and straight forward and the patient data was often
retrospective. Some of them started with one therapy and during the follow up time used
other one (if the implanted stent did not function the patient went under PTD or operation),
the articles often do not detail the material and the number of the used prosthesis and the
exchange frequency do not follow a strict protocol. Because of the retrospective fashion of the
articles the follow up times were not standard the patients were followed as long as it was pos-
sible and in the publication mean or median follow up time was stated. These complaints
show the poor quality of the current literature and all these difficulties made the meta-analysis
troublesome.
To be able to make conclusions first we had to exclude articles because of the above men-
tioned limitations. The widely diversified diseases that lead to the stricture could not be taken
into consideration either and the patients had to be managed as one homogenous cohort.
Interpreting the long term success rate the unsuccessful primary interventions were not
included into the final result in numerous publications typically with endoscopic interven-
tions. Ignoring the initially non-treatable patients the long term success rate is difficult to com-
pare in the different modalities. Due to the lack of available data the statistical comparison is
hardly possible. However, adjudication of a success rate of an intervention should be influ-
enced by the number of initially unsuccessful treatments indicating other—possibly successful
therapeutic modality. On the other hand, comparison of data analyzing long term success rate
according to originally published data and modified long term success rate described previ-
ously did not result in a significant difference.
Even within the same study the follow up times varied in a very wide range. The main limi-
tation of this meta-analysis is the comparability of the selected studies. We made the same sta-
tistical analysis using an alternative weighting method and a conventional one to be able to
make allowance for different follow-up times. Finally, comparing the results of the conven-
tional weighting and the one altered by the follow up time previously described in the meth-
ods, the conclusions are robust concerning this difference. The two weighting methods yields
almost exactly the same estimates and therefore do not affect the conclusion of the analysis.
However, adjudication of a success rate of an intervention should be influenced by the
number of initially unsuccessful treatments indicating other—possibly successful therapeutic
modality. On the other hand, comparison of data analyzing long term success rate according
to originally published data and modified long term success rate described previously did not
result in a significant difference.
In the null hypothesis it was expected that surgery will be as effective as the endoscopic
treatment but on the long term it will provide better results. After the meta-analysis of the liter-
ature we concluded that all compared methods are superior to the single plastic stent place-
ment. Verifying the opinion of the specialists and the results of numerous non-randomized
publications the use of single plastic stent is not recommended. Surgery resulted in the highest
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long term stricture resolution rate with 84%, followed by multiple plastic stent insertion with
79%, the percutaneous transhepatic treatment and the and covered SEMS with 75%, however
the difference was not significant. Thus, the main question is still unanswered, further ran-
domized studies are required. Generally, long term stricture resolution rate irrespectively of
the therapy is still not more than 84%. Considering the benign behavior of the disease and the
life expectancy of the patients it is still unacceptably low. Therefore, the question should be
remain a seething field in the future!
Conclusion
For further results more investigations are needed but only in consideration of the before men-
tioned limitations. Endoscopic treatment shows comparable long term patency compared to
surgical treatment and seems to have priority in first line treatment due to the lower risk of
complications, easy implementation, cost-effectiveness. However, according to the best long
term stricture resolution rate appropriate early surgical treatment should be considered for
patients with complicated biliary- and anastomotic strictures or chronic pancreatitis as not
only second line treatment after endoscopy fails but as initial treatment as well. BBS should be
managed by a multidisciplinary team comprising hepatobiliary surgeons, interventional radi-
ologists and endoscopists. Considering the unacceptable long term recurrence rate, in the near
future not only new techniques but also other therapies involving new devices are needed in
clinical practice.
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